COMPANY PROFILE

QnQuality Pharmaceuticals

Explore full profile

QnQuality Pharmaceuticals is a drug R&D company

Huangpu, ChinaFounded 2019Biotech & Life Sciences

Valuation $50–100M Last recorded · 2019

Total funding $10–50M Disclosed equity funding

Unlock exact values

At a glance

Status: Operational
Founded: 2019
Headquarters: Huangpu, China
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Oct 2019	$15M	$60M	Matrix Partners China · CASH Capital	—
SPINOUT✓Other financing	Jan 2019	$0	—	Shanghai Jiao Tong University	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MLMitotype Precision LabsHigh-throughput mitochondrial assays for drug discovery	Sheffield, United Kingdom	Operational	8	$1.4M	$3.3M
DTDraig TherapeuticsTargeted neuromodulators for major neuropsychiatric disorders treatment	Cardiff, United Kingdom	Operational
LBLeucid BioNext-generation CAR-T cell therapies for refractory cancers	London, United Kingdom	Operational
EXExpanestheticsExpanesthetics is developing new and better analgesics and general anesthetics	Davis, United States	Operational
AUAutolusProgrammed T-cell immunotherapies for cancer and autoimmune diseases	London, United Kingdom	Operational
ZFZ FactorTherapeutic agents for alpha-1-antitrypsin deficiency treatment	Babraham, United Kingdom	Acquired
WAWaveBreakSmall-molecule therapeutics for neurodegenerative diseases	Cambridge, United Kingdom	Operational
MBMatriSys BioscienceClinical stage specialty biopharmaceutical company	San Diego, United States	Operational

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

MCMatrix Partners China
CCCASH Capital

Other known investors1 additional known investor

SUShanghai Jiao Tong University

Talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

🇨🇳 China · Huangpu HQ

Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about QnQuality Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See QnQuality Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.